V 
49.54
+0.02%
Close of 9 Nov 2026, in NOK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Net income
$8.12bn
FY2017FY2025
Free cash flow
$16.04bn
FY2017FY2025
Shareholders' equity
$5.37bn
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Research and development | $433.8m | $38.7m | $35.0m | $31.5m | $32.2m | $25.2m | $19.0m | — | — |
| Operating income | $42.89bn | $3.79bn | $3.52bn | $6.37bn | $3.06bn | $150.6m | $642.8m | $824.4m | $532.5m |
| Net income | $8.12bn | $327.1m | $610.2m | $936.4m | $654.4m | −$1.63bn | $78.4m | $229.6m | $129.4m |
| Diluted earnings per share | 3.25 | 0.13 | 0.24 | 0.38 | 0.26 | -0.65 | 0.03 | 0.09 | 0.05 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $250.92bn | $209.87bn | $185.12bn | $180.40bn | $190.01bn | $20.26bn | $21.52bn | $13.84bn | $4.73bn |
| Cash and short-term investments | $6.72bn | $2.56bn | $7.05bn | $4.27bn | $2.15bn | $262.9m | $195.9m | $997.0m | $12.2m |
| Total liabilities | $245.54bn | $201.88bn | $168.15bn | $166.18bn | $175.47bn | $18.40bn | $17.47bn | $8.11bn | $4.19bn |
| Debt | $57.17bn | $5.29bn | $3.26bn | $3.17bn | $5.15bn | $5.75bn | $8.45bn | $2.39bn | — |
| Shareholders' equity | $5.37bn | $7.99bn | $16.97bn | $14.22bn | $14.55bn | $1.85bn | $4.05bn | $5.74bn | $545.1m |
| Shares outstanding | 2,496m | 2,496m | 2,496m | 2,496m | 2,496m | 2,505m | 2,496m | 2,496m | 2,496m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $44.21bn | $3.41bn | $32.82bn | $54.53bn | $4.58bn | $1.74bn | $1.50bn | $1.53bn | $933.4m |
| Capital spending | −$28.18bn | −$2.94bn | −$25.35bn | −$24.89bn | −$2.58bn | −$1.81bn | −$1.28bn | −$485.6m | −$357.6m |
| Free cash flow | $16.04bn | $466.7m | $7.48bn | $29.64bn | $1.99bn | −$68.0m | $217.5m | $1.04bn | $575.9m |
| Dividends paid | −$11.23bn | −$1.08bn | −$10.65bn | −$7.44bn | −$950.0m | −$450.0m | −$1.70bn | — | — |
Financial ratios
Data as of 7 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | 55.0% | 44.9% | 49.3% | 60.0% | 45.5% | -71.0% |
| Net margin | 10.5% | 4.4% | 9.0% | 9.6% | 10.8% | -56.7% |
| Return on equity | 151.1% | 39.3% | 34.5% | 63.2% | 43.2% | -87.7% |
| Return on assets | 3.2% | 1.5% | 3.2% | 5.0% | 3.3% | -8.0% |
| Free cash flow yield | 5.9% | 4.9% | 4.7% | 6.4% | 5.6% | 2.8% |
| Revenue growth | 9.8% | 8.2% | -30.3% | 61.8% | 110.7% | 1.7% |
| Earnings growth | 158.8% | -46.4% | -34.8% | 43.1% | -140.2% | -2174.1% |
| Current ratio | 0.61x | 0.67x | 0.78x | 0.52x | 0.66x | 1.58x |
| Debt to equity | 10.43x | 6.19x | 1.84x | 2.06x | 3.04x | 5.33x |
| Equity ratio | 2.1% | 3.8% | 9.2% | 7.9% | 7.7% | 9.2% |
| Interest coverage | 29.98x | 160.53x | 478.13x | 722.17x | 15.64x | -12.27x |
| R&D as a share of sales | 0.6% | 0.5% | 0.5% | 0.3% | 0.5% | 0.9% |
| Buybacks as a share of market value | -0.0% | 0.0% | 0.0% | 0.0% | 0.3% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 99.5% | 93.4% | — |
| Operating income | 88.8% | 209.7% | — |
| Net income | 105.5% | — | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Price to earnings | 1.1 | 29.3 | 14.3 | 9.8 |
| Price to sales | 0.1 | 1.3 | 1.3 | 0.9 |
Dividends and splits
Per share, in the currency the company pays
Paid for 4 years. Last went ex-dividend on 21 Aug 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Paid in the year | 2.465 | 4.891 | 4.692 | 4.669 | 3.077 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.